News

With a "terrible" job market, empty labs, and mounting competition from China, the life sciences industry is under massive ...
Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.
before taking up the CEO role at Voyager Therapeutics. Analysts at Jefferies had previously suggested that Biogen could be heading for a takeover if Clarity AD had failed to show efficacy.
Israeli drugmaker Teva has appointed former Sandoz and Biogen executive Richard Francis to succeed current CEO Kare Schultz, who is scheduled to retire at the end of this year. Francis ...
US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing ...
The company said it would remove Biogen and add Regeneron in its 2025 primary peer group. Gilead paid CEO Daniel O’Day $23.7 million in 2024, a 5% increase from his $22.6 million salary in 2023. The ...
Royalty Pharma (RPRX) announced the appointment of Vlad Coric to the company’s board of directors, effective immediately. Vlad Coric is the ...
Amazon shoppers can likely expect some prices to rise due to the ongoing global trade war, the company’s CEO admitted. The online retailer’s network of third-party sellers “will pass that ...
Vertex Pharmaceuticals sees early success with Journavx painkiller, potential revenue growth from drug and gene therapy.
Epaulet is a menswear brand that makes all its clothing in Los Angeles, New Jersey, or Rochester. Its owner, Eva Kuhle, says Trump's tariff policies are too inconsistent to help US manufacturing ...
Biogen Pharmachem Industries Ltd share price was down by -3.16% from the previous closing price of ₹0.95. Who are peers of Biogen Pharmachem Industries Ltd? The peers of Biogen Pharmachem ...
Nvidia CEO Jensen Huang likes to conduct intense, public examinations of his team's work. Stephen Witt's book about Huang and Nvidia debuted in the US on Tuesday. Witt experienced Huang's ire when ...